Wei Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wei Xu has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Jiafeng Chen
Department of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China
1 shared publication - Li Chen
Department of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, 530021, China
1 shared publication - Lijuan Huang
Department of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China
1 shared publication - Minshan Xie
Department of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China
1 shared publication - Qingchun Qin
Department of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China
1 shared publication - Rongxing Qin
Department of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China
1 shared publication
Latest Publications
- Open Access
- 22 March 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (3) , 524
Somatic Cell Reprogramming for Nervous System Diseases: Techniques, Mechanisms, Potential Applications, and Challenges
Nervous system diseases present significant challenges to the neuroscience community due to ethical and practical constraints that limit access to appropriate research materials. Somatic cell reprogramming has been proposed as a novel way to obtain neurons. Various emerging techniques have been used to reprogram mature and differentiated cells into neurons. This review provides an overview of somatic cell reprogramming for neurological research and therapy, focusing on neural reprogramming and generating different neural cell types. We examine the mechanisms involved in reprogramming and the challenges that arise. We herein summarize cell reprogramming strategies to generate neurons, including transcription factors, small molecules, and microRNAs, with a focus on different types of cells.. While reprogramming somatic cells into neurons holds the potential for understanding neurological diseases and developing therapeutic applications, its limitations and risks must be carefully considered. Here, we highlight the potential benefits of somatic cell reprogramming for neurological disease research and therapy. This review contributes to the field by providing a comprehensive overview of the various techniques used to generate neurons by cellular reprogramming and discussing their potential applications.
- 22 March 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (3) , 524
Open AccessSomatic Cell Reprogramming for Nervous System Diseases: Techniques, Mechanisms, Potential Applications, and Challenges
Nervous system diseases present significant challenges to the neuroscience community due to ethical and practical constraints that limit access to appropriate research materials. Somatic cell reprogramming has been proposed as a novel way to obtain neurons. Various emerging techniques have been used to reprogram mature and differentiated cells into neurons. This review provides an overview of somatic cell reprogramming for neurological research and therapy, focusing on neural reprogramming and generating different neural cell types. We examine the mechanisms involved in reprogramming and the challenges that arise. We herein summarize cell reprogramming strategies to generate neurons, including transcription factors, small molecules, and microRNAs, with a focus on different types of cells.. While reprogramming somatic cells into neurons holds the potential for understanding neurological diseases and developing therapeutic applications, its limitations and risks must be carefully considered. Here, we highlight the potential benefits of somatic cell reprogramming for neurological disease research and therapy. This review contributes to the field by providing a comprehensive overview of the various techniques used to generate neurons by cellular reprogramming and discussing their potential applications.